Option Care Health, Inc. (NASDAQ: OPCH)

Option Care Health, Inc., often recognized by its ticker symbol OPCH, operates in the healthcare industry, specifically focusing on home and alternate site infusion services within the United States. The company was established in 2019, following the merger of HC Group Holdings II, Inc. and BioScrip, Inc., making it the largest independent provider of home and alternate site infusion services in the country, with a network of 177 locations spread across 43 states.

Option Care Health's primary business activities revolve around providing infusion services, which encompass a wide range of therapies for both chronic and acute conditions. These services are delivered to patients in the comfort of their homes or at one of the company's ambulatory infusion suites. The therapy offerings are diverse, including anti-infectives, nutrition support, chronic inflammatory disorders, neurological disorders, immunoglobulin therapy, and other treatments for various conditions. Additionally, the company provides therapies for pain management, chemotherapy, and respiratory medication, ensuring comprehensive care for its patients.

The home and alternate site infusion market is highly competitive, with Option Care Health facing rivals such as Optum Infusion Pharmacy, Coram CVS/specialty infusion services, Amerita Specialty Pharmacy, KabaFusion, and Soleo Health. However, the company maintains a competitive edge through its extensive national network, the broad spectrum of infusion services it provides, and its ability to offer convenient and comfortable treatment settings for patients.

In terms of revenue generation, Option Care Health primarily caters to managed care organizations, local and regional patient referral sources, and pharmaceutical manufacturers. The company's largest payer accounted for approximately 14% of its revenue in the year ending December 31, 2023, with no other single payer representing more than 10%. Furthermore, the company provides services that are directly reimbursable through government healthcare programs like Medicare and Medicaid.

Option Care Health's product and service portfolio includes home and alternate site infusion services, specialty pharmacy services, and pharmacy compounding services. The home and alternate site infusion services cater to patients with chronic and acute conditions, offering therapies in a convenient and comfortable setting, while specialty pharmacy services target patients with complex medical conditions, providing customized medications and clinical support. Pharmacy compounding services cater to patients requiring customized medications not commercially available.